Talus Bioscience Inc.
Seattle, WA Doing business as Talus Bioscience Inc. Talus Bioscience
- UEI
- NKSRDDRQK175
- CAGE
- 8QM26
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 550 17th Ave #550, Seattle, WA 98122, USA
- Website
- talus.bio
- Founded
- 2020
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Talus Bioscience Inc.
Talus Bioscience Inc., a for-profit biopharmaceutical research company based in Seattle, Washington, operates as a prime recipient of federal research grants focused on artificial intelligence-driven drug discovery and high-throughput functional proteomics, with no federal contracting activity in the source data. The vendor competes exclusively in the grant space through the National Institutes of Health and National Science Foundation, with 100% of recent awards as prime recipient grants (zero subcontract or sub-grant involvement).
Talus Bioscience's federal grant portfolio centers on translational drug discovery platforms targeting previously undruggable proteins implicated in cancer, fibrosis, and immunological disease. The company's core capability is STRATEGIAN, an AI-powered drug discovery platform integrated with Talus's proprietary TF-SCAN high-throughput functional proteomics technology and the CHESS-DIA mass spectrometry-based proteomics method. Representative recent grants include a $1,035,634 Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded July 1, 2026, running through June 30, 2028, focused on optimizing protein and compound representation models, discovering novel transcription factor inhibitors through active learning, and developing scalable cloud-based data infrastructure; a $17 thousand award from the National Cancer Institute (NCI) for simultaneous pharmacological profiling of oncogenic gene fusion proteins in cancer, specifically targeting mixed lineage leukemia (MLL) rearranged leukemia (awarded July 2023, ultimate completion June 2025); an award from NCATS for activity-based regulome profiling for discovery of covalent transcription factor inhibitors (awarded August 2023, completed January 2026); and a $17 thousand award from the National Institute of General Medical Sciences for deep learning methods to accelerate discovery of drugs targeting gene regulatory proteins, developing compressed sensing algorithms for mass spectrometry analysis (awarded September 2023, completed August 2024). Work is performed in Seattle, Washington.
Customer concentration is split across three NIH institutes and the National Science Foundation. The National Cancer Institute and National Center for Advancing Translational Sciences each account for three awards in the recent portfolio, while the National Institute of General Medical Sciences and NSF Division of Industrial Innovation each carry one. One award reaches ultimate completion inside the next twenty-four months, presenting a recompete opportunity in that window. Award velocity across the past four years shows two awards in 2021, two in 2022, three in 2023, and one in 2026, with combined dollars obligated ($11.3 million) significantly exceeding combined potential value (reflecting the grant space's post-award funding obligation patterns).
Quick answers
What is Talus Bioscience Inc.'s UEI?
Talus Bioscience Inc.'s Unique Entity ID (UEI) in SAM.gov is NKSRDDRQK175.
What is Talus Bioscience Inc.'s CAGE code?
Talus Bioscience Inc.'s CAGE code is 8QM26.
What is Talus Bioscience Inc.'s primary NAICS code?
Talus Bioscience Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Talus Bioscience Inc. located?
Talus Bioscience Inc.'s physical address in SAM.gov is 550 17th Ave #550, Seattle, WA 98122, USA.
Is Talus Bioscience Inc. registered in SAM.gov?
Yes. Talus Bioscience Inc.'s SAM.gov registration is active through September 29, 2027.
What is Talus Bioscience Inc.'s most recent federal award?
Talus Bioscience Inc.'s most recent federal grant award is Deployment of an AI platform to accelerate transcription factor drug development - project summary transcription factors… (R44TR005930), from National Center for Advancing Translational Sciences, on July 1, 2026.
On GovTribe
See Talus Bioscience Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors